Healogics Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -1.80%
- Profit Growth -5.13%
- Ebitda 31.22%
- Net Worth 21.14%
- Total Assets 27.53%
About Healogics Pharmaceuticals
Healogics Pharmaceuticals Private Limited (HPPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 September 2014 and has a history of Ten years and four months. Its registered office is in Patna, Bihar, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kumar Krishna, Sanjay Kumar, Kumar Krishna, and One other member serve as directors at the Company.
Company Details
-
Location
Patna, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999BR2014PTC022990
-
Company No.
022990
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Sep 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Healogics Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kumar Krishna
|
Director | 24-Sep-2014 | Current |
|
Sanjay Kumar
|
Director | 23-Dec-2017 | Current |
|
Kumar Krishna
|
Director | 24-Sep-2014 | Current |
|
Sunil Singh
|
Director | 23-Dec-2017 | Current |
Financial Performance of Healogics Pharmaceuticals.
Healogics Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 1.8% decrease. The company also saw a slight decrease in profitability, with a 5.13% decrease in profit. The company's net worth Soared by an impressive increase of 21.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Healogics Pharmaceuticals?
Unlock access to Healogics Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Healogics Pharmaceuticals?
Unlock and access historical data on people associated with Healogics Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Healogics Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Healogics Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
